TrialBlood2019
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia.
Antonio Piga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
52 papers cite it
this papertrialcites it